Boyd Biomedical, Inc.

© 2026 Boyd Biomedical, Inc.

commercial-phases_LBB_phase-6_growth_color_800x800
Phase 6

Growth

We turn traction into market leadership. Early adoption proves a device works. Sustained growth proves a brand can defend its position as the market responds.

×

Please feel out the form below and someone from our team will contact you shortly.
Phase Overview

Growth is the phase where a company moves beyond initial market entry toward sustained adoption, market expansion, and competitive differentiation. The device has commercial traction, but building market leadership is ongoing work: disseminating clinical evidence, expanding payer coverage, developing the portfolio, and continuing to invest in the brand. This is also where the strategy established at Foundation is tested against real market conditions and either reinforced or revised. Growth can include international expansion, new indication development, and portfolio extension as the company matures.

What Happens in This Phase

Each phase draws on a different combination of our disciplines and sub-disciplines. These are the ones that sustain adoption and build a defensible market position.

Integrated Marketing Campaigns

Multichannel campaigns sustained and refreshed to drive continued awareness, education, and adoption beyond launch.

Performance Metrics & Optimization

Metrics developed and refined so spend, message, and channel are optimized against what's actually driving adoption.

KOL Engagement

Clinical relationships sustained and expanded as advocates, investigators, and voices in the wider community.

Evidence-Based Content

Published data, real-world evidence, and clinical outcomes translated into content that moves skeptical audiences.

Payer Coverage Expansion

Reimbursement broadened across plans, regions, and settings to remove the access barriers that cap adoption.

Sales Enablement

Field tools evolved as the competitive set shifts and the sales conversation moves from introduction to displacement.

Portfolio & Brand Extension

Brand architecture extended to support new products, indications, and markets without diluting what you've built.

Repositioning

Positioning revisited as competitors respond and the market matures, reinforcing or revising the original strategy.

AdobeStock_134638823_Color_800x800
What You Walk Away With

A brand built to lead rather than just to launch: sustained integrated campaigns, performance metrics driving optimization, an expanded KOL network, evidence-based content from real-world use, broadened payer coverage, evolved sales enablement, brand architecture ready for portfolio and geographic extension, and positioning tested against actual market conditions.

Why This Phase Matters

Most biomedical brands are built for a launch and then left to run on momentum. Markets don't cooperate with that. Competitors respond, clinical opinion shifts, coverage decisions change, and the positioning that won early adopters often fails to convince the mainstream buyers who follow them. Continued investment is what separates a device that found a niche from one that defined a category. It's also where the foundation pays off or doesn't, because a brand built deliberately can be extended, and one assembled under pressure has to be rebuilt.

commercial-phases_LBB_hero_color_800x800
BACK TO

Commercial Phases

You can engage with us in any phase of your commercialization from foundational strategy to market growth. Return to the full view to find the best place to get started. 

×

Please feel out the form below and someone from our team will contact you shortly.
Content Card - Just Mighty - Launch - Two Color - Full (1920 x 1080)
Logo - Just Mighty - White Logo (400 x 400)

Your innovation Just Might change the world. But is your brand up to the task? We help you turn Just Might into Just Mighty.